Page last updated: 2024-09-02

triptolide and Lymphoma, Primary Effusion

triptolide has been researched along with Lymphoma, Primary Effusion in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Guo, W; Liu, Y; Long, C; Sun, X; Wang, C; Wang, H; Wang, J1
Guo, W; Long, C; Sun, X; Wang, H; Wang, J; Zhou, H1

Other Studies

2 other study(ies) available for triptolide and Lymphoma, Primary Effusion

ArticleYear
Triptolide inhibits transcription of hTERT through down-regulation of transcription factor specificity protein 1 in primary effusion lymphoma cells.
    Biochemical and biophysical research communications, 2016, Jan-01, Volume: 469, Issue:1

    Topics: Antineoplastic Agents, Alkylating; Apoptosis; Cell Line, Tumor; Cell Proliferation; Diterpenes; Down-Regulation; Epoxy Compounds; Humans; Lymphoma, Primary Effusion; Phenanthrenes; Sp1 Transcription Factor; Telomerase; Transcriptional Activation

2016
Triptolide decreases expression of latency-associated nuclear antigen 1 and reduces viral titers in Kaposi's sarcoma-associated and herpesvirus-related primary effusion lymphoma cells.
    International journal of oncology, 2016, Volume: 48, Issue:4

    Topics: Animals; Antigens, Viral; Antineoplastic Agents, Alkylating; Cell Line, Tumor; Cell Proliferation; Cell Survival; Diterpenes; Down-Regulation; Epoxy Compounds; Gene Expression Regulation, Neoplastic; Gene Expression Regulation, Viral; Herpesvirus 8, Human; Humans; Lymphoma, Primary Effusion; Mice; Nuclear Proteins; Phenanthrenes; Sarcoma, Kaposi; STAT3 Transcription Factor; Viral Load; Xenograft Model Antitumor Assays

2016